Cargando…
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
We review articles describing intravitreal injection of anti-VEGF drug trials, while discussing the mechanisms of the action of anti-VEGF antibodies, and also evaluating their outcomes. Intraocular injections of anti-VEGF drug are considered to be an effective treatment for macular edema after retin...
Autores principales: | Kimoto, Kenichi, Kubota, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216356/ https://www.ncbi.nlm.nih.gov/pubmed/22132316 http://dx.doi.org/10.1155/2012/852183 |
Ejemplares similares
-
Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
por: Kubota, Toshiaki, et al.
Publicado: (2012) -
Biological drug therapy for ocular angiogenesis: Anti‐VEGF agents and novel strategies based on nanotechnology
por: Formica, María L., et al.
Publicado: (2021) -
Vascular permeability, vascular hyperpermeability and angiogenesis
por: Nagy, Janice A., et al.
Publicado: (2008) -
Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis
por: Xu, Manhong, et al.
Publicado: (2022) -
Neuropilin Regulation of Angiogenesis, Arteriogenesis, and Vascular Permeability
por: Plein, Alice, et al.
Publicado: (2014)